A Phase 1b Study of CG0070 combined with nivolumab in cisplatin ineligible patients with muscle invasive bladder cancer
Publication
, Conference
Li, R; Sexton, W; Spiess, P; Gilbert, S; Pow-Sang, J; Zhang, J; Borjas, G; Grandi, P; Burke, J; Jain, R; Conejo-Garcia, J
Published in: CANCER RESEARCH
2022
Duke Scholars
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2022
Volume
82
Issue
12
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Li, R., Sexton, W., Spiess, P., Gilbert, S., Pow-Sang, J., Zhang, J., … Conejo-Garcia, J. (2022). A Phase 1b Study of CG0070 combined with nivolumab in cisplatin ineligible patients with muscle invasive bladder cancer. In CANCER RESEARCH (Vol. 82).
Li, Roger, Wade Sexton, Phillipe Spiess, Scott Gilbert, Julio Pow-Sang, Jingsong Zhang, Gustavo Borjas, et al. “A Phase 1b Study of CG0070 combined with nivolumab in cisplatin ineligible patients with muscle invasive bladder cancer.” In CANCER RESEARCH, Vol. 82, 2022.
Li R, Sexton W, Spiess P, Gilbert S, Pow-Sang J, Zhang J, et al. A Phase 1b Study of CG0070 combined with nivolumab in cisplatin ineligible patients with muscle invasive bladder cancer. In: CANCER RESEARCH. 2022.
Li, Roger, et al. “A Phase 1b Study of CG0070 combined with nivolumab in cisplatin ineligible patients with muscle invasive bladder cancer.” CANCER RESEARCH, vol. 82, no. 12, 2022.
Li R, Sexton W, Spiess P, Gilbert S, Pow-Sang J, Zhang J, Borjas G, Grandi P, Burke J, Jain R, Conejo-Garcia J. A Phase 1b Study of CG0070 combined with nivolumab in cisplatin ineligible patients with muscle invasive bladder cancer. CANCER RESEARCH. 2022.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2022
Volume
82
Issue
12
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis